Bypass covid-19 drug patents demand US state attorney generals

Bypass covid-19 drug patents demand US state attorney generals

The pandemic has puts compulsory licensing firmly on the agenda in the country that is friendliest to life sciences IP owners

Unlock unlimited access to all IAM content